These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 30076472)

  • 21. Maternal serum levels of perfluoroalkyl substances in early pregnancy and offspring birth weight.
    Wikström S; Lin PI; Lindh CH; Shu H; Bornehag CG
    Pediatr Res; 2020 May; 87(6):1093-1099. PubMed ID: 31835271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations between lipid/lipoprotein levels and perfluoroalkyl substances among US children aged 6-11 years.
    Jain RB; Ducatman A
    Environ Pollut; 2018 Dec; 243(Pt A):1-8. PubMed ID: 30170203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma Concentrations of Per- and Polyfluoroalkyl Substances and Body Composition From Mid-Childhood to Early Adolescence.
    Janis JA; Rifas-Shiman SL; Seshasayee SM; Sagiv S; Calafat AM; Gold DR; Coull BA; Rosen CJ; Oken E; Fleisch AF
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3760-e3770. PubMed ID: 33740056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attention deficit/hyperactivity disorder and childhood autism in association with prenatal exposure to perfluoroalkyl substances: a nested case-control study in the Danish National Birth Cohort.
    Liew Z; Ritz B; von Ehrenstein OS; Bech BH; Nohr EA; Fei C; Bossi R; Henriksen TB; Bonefeld-Jørgensen EC; Olsen J
    Environ Health Perspect; 2015 Apr; 123(4):367-73. PubMed ID: 25616253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prenatal and childhood perfluoroalkyl substances exposures and children's reading skills at ages 5 and 8years.
    Zhang H; Yolton K; Webster GM; Ye X; Calafat AM; Dietrich KN; Xu Y; Xie C; Braun JM; Lanphear BP; Chen A
    Environ Int; 2018 Feb; 111():224-231. PubMed ID: 29241079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood.
    Granum B; Haug LS; Namork E; Stølevik SB; Thomsen C; Aaberge IS; van Loveren H; Løvik M; Nygaard UC
    J Immunotoxicol; 2013; 10(4):373-9. PubMed ID: 23350954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of diet with per- and polyfluoroalkyl substances in plasma and human milk in the New Hampshire Birth Cohort Study.
    Wang Y; Gui J; Howe CG; Emond JA; Criswell RL; Gallagher LG; Huset CA; Peterson LA; Botelho JC; Calafat AM; Christensen B; Karagas MR; Romano ME
    Sci Total Environ; 2024 Jul; 933():173157. PubMed ID: 38740209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
    Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
    Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prenatal Exposure to Perfluoroalkyl Substances and Adiposity in Early and Mid-Childhood.
    Mora AM; Oken E; Rifas-Shiman SL; Webster TF; Gillman MW; Calafat AM; Ye X; Sagiv SK
    Environ Health Perspect; 2017 Mar; 125(3):467-473. PubMed ID: 27352404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perfluoroalkyl substances and sex hormones in postmenopausal women: NHANES 2013-2016.
    Wang Y; Aimuzi R; Nian M; Zhang Y; Luo K; Zhang J
    Environ Int; 2021 Apr; 149():106408. PubMed ID: 33548847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gestational and childhood exposure to per- and polyfluoroalkyl substances and cardiometabolic risk at age 12 years.
    Li N; Liu Y; Papandonatos GD; Calafat AM; Eaton CB; Kelsey KT; Cecil KM; Kalkwarf HJ; Yolton K; Lanphear BP; Chen A; Braun JM
    Environ Int; 2021 Feb; 147():106344. PubMed ID: 33418195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors associated with exposure of pregnant women to perfluoroalkyl acids in North China and health risk assessment.
    Yang J; Wang H; Du H; Xu L; Liu S; Yi J; Qian X; Chen Y; Jiang Q; He G
    Sci Total Environ; 2019 Mar; 655():356-362. PubMed ID: 30471604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prenatal perfluoroalkyl substances and newborn anogenital distance in a Canadian cohort.
    Arbuckle TE; MacPherson S; Foster WG; Sathyanarayana S; Fisher M; Monnier P; Lanphear B; Muckle G; Fraser WD
    Reprod Toxicol; 2020 Jun; 94():31-39. PubMed ID: 32283250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Perfluoroalkyl and Polyfluoroalkyl Substances With Premature Ovarian Insufficiency in Chinese Women.
    Zhang S; Tan R; Pan R; Xiong J; Tian Y; Wu J; Chen L
    J Clin Endocrinol Metab; 2018 Jul; 103(7):2543-2551. PubMed ID: 29986037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prenatal Maternal Serum Concentrations of Per- and Polyfluoroalkyl Substances in Association with Autism Spectrum Disorder and Intellectual Disability.
    Lyall K; Yau VM; Hansen R; Kharrazi M; Yoshida CK; Calafat AM; Windham G; Croen LA
    Environ Health Perspect; 2018 Jan; 126(1):017001. PubMed ID: 29298162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations of Prenatal Per- and Polyfluoroalkyl Substance (PFAS) Exposures with Offspring Adiposity and Body Composition at 16-20 Years of Age: Project Viva.
    Zhang M; Rifas-Shiman SL; Aris IM; Fleisch AF; Lin PD; Nichols AR; Oken E; Hivert MF
    Environ Health Perspect; 2023 Dec; 131(12):127002. PubMed ID: 38054701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prenatal Exposure to Perfluoroalkyl Substances and Cardiometabolic Risk in Children from the Spanish INMA Birth Cohort Study.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Romaguera D; Fernández-Barrés S; Santa-Marina L; Basterretxea M; Schettgen T; Valvi D; Vioque J; Sunyer J; Vrijheid M
    Environ Health Perspect; 2017 Sep; 125(9):097018. PubMed ID: 28934720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exposure to perfluoroalkyl substances and thyroid function in pregnant women and children: A systematic review of epidemiologic studies.
    Ballesteros V; Costa O; Iñiguez C; Fletcher T; Ballester F; Lopez-Espinosa MJ
    Environ Int; 2017 Feb; 99():15-28. PubMed ID: 27884404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prenatal exposure to perfluorinated chemicals and relationship with allergies and infectious diseases in infants.
    Okada E; Sasaki S; Saijo Y; Washino N; Miyashita C; Kobayashi S; Konishi K; Ito YM; Ito R; Nakata A; Iwasaki Y; Saito K; Nakazawa H; Kishi R
    Environ Res; 2012 Jan; 112():118-25. PubMed ID: 22030285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prenatal exposure to perfluoroalkyl substances, immune-related outcomes, and lung function in children from a Spanish birth cohort study.
    Manzano-Salgado CB; Granum B; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Gascón M; Martínez D; Guxens M; Basterretxea M; Zabaleta C; Schettgen T; Sunyer J; Vrijheid M; Casas M
    Int J Hyg Environ Health; 2019 Jul; 222(6):945-954. PubMed ID: 31262703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.